Wird geladen...
Reported Sildenafil Side Effects in Pediatric Pulmonary Hypertension Patients
Background: Sildenafil, a phosphodiestase type 5 inhibitor, was approved in 2005 for the treatment of pulmonary arterial hypertension (PAH) in adults and is commonly used off-label for pediatric patients. Little is known, however, about sildenafil’s side effects in this population. Methods: Single i...
Gespeichert in:
| Veröffentlicht in: | Front Pediatr |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Frontiers Media S.A.
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4353247/ https://ncbi.nlm.nih.gov/pubmed/25806361 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fped.2015.00012 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|